Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, United States of America; Center for Genome Engineering and Institute of Human Genetics, University of Minnesota, Minneapolis, Minnesota, United States of America; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, United States of America; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
PLoS One. 2014 May 5;9(5):e96114. doi: 10.1371/journal.pone.0096114. eCollection 2014.
The advent of Transcription Activator-Like Effector Nucleases (TALENs), and similar technologies such as CRISPR, provide a straightforward and cost effective option for targeted gene knockout (KO). Yet, there is still a need for methods that allow for enrichment and isolation of modified cells for genetic studies and therapeutics based on gene modified human cells. We have developed and validated two methods for simple enrichment and isolation of single or multiplex gene KO's in transformed, immortalized, and human progenitor cells. These methods rely on selection of a phenotypic change such as resistance to a particular drug or ability to grow in a selective environment. The first method, termed co-transposition, utilizes integration of a piggyBac transposon vector encoding a drug resistance gene. The second method, termed co-targeting, utilizes TALENs to KO any gene that when lost induces a selectable phenotype. Using these methods we also show removal of entire genes and demonstrate that TALENs function in human CD34+ progenitor cells. Further, co-transposition can be used to generate conditional KO cell lines utilizing an inducible cDNA rescue transposon vector. These methods allow for robust enrichment and isolation of KO cells in a rapid and efficient manner.
转录激活因子样效应物核酸酶(TALENs)的出现以及 CRISPR 等类似技术为靶向基因敲除(KO)提供了一种直接且经济有效的选择。然而,仍然需要一些方法来富集和分离经过基因修饰的细胞,以便基于基因修饰的人类细胞进行遗传研究和治疗。我们已经开发并验证了两种方法,用于简单地富集和分离转化、永生化和人祖细胞中的单基因或多基因 KO。这些方法依赖于选择表型变化,例如对特定药物的抗性或在选择性环境中生长的能力。第一种方法称为共转位,利用整合编码药物抗性基因的 piggyBac 转座子载体。第二种方法称为共靶向,利用 TALENs 敲除任何导致可选择表型的基因。使用这些方法,我们还证明了可以去除整个基因,并证明 TALENs 在人 CD34+祖细胞中起作用。此外,共转位可用于利用诱导型 cDNA 挽救转座子载体生成条件性 KO 细胞系。这些方法允许以快速有效的方式对 KO 细胞进行强大的富集和分离。